The stock has dropped 46% so far this year and 56% in the past three months. Kasimov continues to rate Moderna stock at In Line, the equivalent of Neutral, despite the cut to its stock-price target.

A price target is an analyst's best guess as to where stock prices are headed in the next 12-18 months. Read on for more about how that's useful today.

Going by our Target's Valuation, with an EPS estimate of around $7.62 and a P/E multiple of 18.1x in fiscal 2023, this translates into a price of $138, which is almost 28% higher than the current ...

In recent trading, shares of XPeng Inc (Symbol: XPEV) have crossed above the average analyst 12-month target price of $13.99, changing hands for $14.13/share. When a stock reaches the target an ...

Valuation. Now expecting adjusted full-year earnings of $8.30 to $8.90 per share, Target is trading at 14.77 times earnings on a price-to-earnings (P/E) ratio based on the high end of that ...

The analysts raised the price target to $1,065 from $825, the highest of all analysts who cover the stock tracked by Visible Alpha. Oppenheimer said Netflix "remains the only investable mainstream ...

Target shares jumped after the company snapped a streak of sales declines, saying price cuts had helped drive more store visits, and lifted profit goals for the year. Target stock stood more than ...